Gabelli & CO Investment Advisers, Inc. Seagen Inc. Transaction History

Gabelli & CO Investment Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$191.51 - $216.16 $4.86 Million - $5.49 Million	25,400 Added 38.14%	92,000 $19.5 Million
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $9.51 Million - $10.5 Million	50,700 Added 318.87%	66,600 $12.8 Million
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $2.03 Million - $3.23 Million	15,900 New	15,900 $3.22 Million
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $338,175 - $450,275	2,500 New	2,500 $342,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.